Standard BioTools Analyst Ratings
Standard BioTools Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/12/2023 | 75.44% | Keybanc | → $4 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 07/12/2023 | 75.44% | Keybanc | → 4 美元 | 启动覆盖开启 | → 超重 |
What is the target price for Standard BioTools (LAB)?
Standard BioTools (LAB) 的目标价格是多少？
The latest price target for Standard BioTools (NASDAQ: LAB) was reported by Keybanc on July 12, 2023. The analyst firm set a price target for $4.00 expecting LAB to rise to within 12 months (a possible 75.44% upside). 1 analyst firms have reported ratings in the last year.
Keybanc于2023年7月12日公布了标准BioTools（纳斯达克股票代码：LAB）的最新目标股价。这家分析公司将目标股价定为4.00美元，预计LAB将在12个月内升至4美元（可能上涨75.44％）。去年有1家分析公司公布了评级。
What is the most recent analyst rating for Standard BioTools (LAB)?
分析师对标准 BioTools (LAB) 的最新评级是多少？
The latest analyst rating for Standard BioTools (NASDAQ: LAB) was provided by Keybanc, and Standard BioTools initiated their overweight rating.
Standard BioTools（纳斯达克股票代码：LAB）的最新分析师评级由Keybanc提供，Standard BioTools启动了增持评级。
When is the next analyst rating going to be posted or updated for Standard BioTools (LAB)?
Standard BioTools (LAB) 的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Standard BioTools, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Standard BioTools was filed on July 12, 2023 so you should expect the next rating to be made available sometime around July 12, 2024.
分析师在进行了广泛的研究（包括浏览公开财务报表、与Standard BioTools的高管和客户交谈以及听取财报电话会议）后得出了股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Standard BioTools的最新评级是在2023年7月12日提交的，因此您应该预计下一个评级将在2024年7月12日左右公布。
Is the Analyst Rating Standard BioTools (LAB) correct?
分析师评级标准 BioTools (LAB) 正确吗？
While ratings are subjective and will change, the latest Standard BioTools (LAB) rating was a initiated with a price target of $0.00 to $4.00. The current price Standard BioTools (LAB) is trading at is $2.28, which is within the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的标准BioTools（LAB）评级是最初的，目标股价为0.00美元至4.00美元。Standard BioTools（LAB）目前的交易价格为2.28美元，在分析师的预测区间内。